Clinical features, risk factors, diagnosis, and treatment of trimethoprim-sulfamethoxazole-induced hypoglycemia

OBJECTIVE: Hypoglycemia is a sporadic and serious adverse reaction of trimethoprim-sulfamethoxazole (TMP-SMX) due to its sulfonylurea-like effect. This study explored the clinical characteristics, risk factors, treatment, and prognosis of TMP-SMX-induced hypoglycemia. METHODS: Case reports and serie...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunjiang, Fang, Weijin, Li, Zuojun, Sun, Linli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944732/
https://www.ncbi.nlm.nih.gov/pubmed/36843590
http://dx.doi.org/10.3389/fendo.2023.1059522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944732/
https://www.ncbi.nlm.nih.gov/pubmed/36843590
http://dx.doi.org/10.3389/fendo.2023.1059522

Ejemplares similares